ENOVANT Trademark

Trademark Overview


On Tuesday, September 11, 2018, a trademark application was filed for ENOVANT with the United States Patent and Trademark Office. The USPTO has given the ENOVANT trademark a serial number of 88111828. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, September 8, 2021. This trademark is owned by Roivant Sciences GmbH. The ENOVANT trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Insurance & Financial Services, and Computer & Software Services & Scientific Services categories with the following description:

Computer software using artificial intelligence for providing, analyzing and generating reports; computer software for providing, analyzing and generating reports; computer software for data processing; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceutical and biomedical research and development, clinical and post-market trials, and the provision of medical and healthcare services; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer...

Business consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; professional business analysis and consultancy and statistical analysis in the fields of healthcare, biomedicine, pharmaceuticals, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive inte...

Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; financial research related to financial instruments

Scientific and technological services, namely, scientific research and analysis, and diagnostic services in the field of pharmaceuticals and biomedicine; industrial analysis and research services in the field of pharmaceuticals and biomedicine; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; conducting clinical trials and post-market trials; epidemiological research services, pharmacoepidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, and pharmacoepidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmacoepidemiological research, and clinical t...
enovant

General Information


Serial Number88111828
Word MarkENOVANT
Filing DateTuesday, September 11, 2018
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, September 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements


Goods and ServicesComputer software using artificial intelligence for providing, analyzing and generating reports; computer software for providing, analyzing and generating reports; computer software for data processing; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceutical and biomedical research and development, clinical and post-market trials, and the provision of medical and healthcare services; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information
Goods and ServicesBusiness consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; professional business analysis and consultancy and statistical analysis in the fields of healthcare, biomedicine, pharmaceuticals, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare from an on-line database; providing commercial and business contact information within the scientific research and medical communities to achieve advances in the field of healthcare; business networking services within the scientific research and medical communities to achieve advances in the field of healthcare; compilation of data, analysis of business data and professional business analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare for business purposes; compilation of data, analysis of business data and professional business analysis for medical and healthcare for business purposes; providing reimbursement benchmarking information and other market intelligence to healthcare organizations; collecting and professional business analysis of claims data from healthcare organizations for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for business purposes
Goods and ServicesFinancial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; financial research related to financial instruments
Goods and ServicesScientific and technological services, namely, scientific research and analysis, and diagnostic services in the field of pharmaceuticals and biomedicine; industrial analysis and research services in the field of pharmaceuticals and biomedicine; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; conducting clinical trials and post-market trials; epidemiological research services, pharmacoepidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, and pharmacoepidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmacoepidemiological research, and clinical trial and post-market trial data via a computer database or the Internet; providing scientific research information in the fields of healthcare, biomedicine, pharmaceuticals, and clinical and post-market clinical trials; providing temporary use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; compiling data for research and analysis for medical science purposes in the field of healthcare, pharmaceuticals, biomedicine, clinical trials and post-market trials

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code8 - Abandoned
Class Status DateWednesday, September 8, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code8 - Abandoned
Class Status DateWednesday, September 8, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code8 - Abandoned
Class Status DateWednesday, September 8, 2021
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, September 8, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoivant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameRoivant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Wednesday, September 8, 2021ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Wednesday, September 8, 2021ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, September 8, 2021OPPOSITION TERMINATED NO. 999999
Wednesday, September 8, 2021OPPOSITION DISMISSED NO. 999999
Wednesday, January 22, 2020OPPOSITION INSTITUTED NO. 999999
Wednesday, January 22, 2020OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 19, 2019ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 15, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, November 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, October 29, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2019NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2019NON-FINAL ACTION WRITTEN
Monday, April 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 16, 2018NON-FINAL ACTION E-MAILED
Tuesday, October 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, October 10, 2018ASSIGNED TO EXAMINER
Tuesday, October 2, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sunday, September 30, 2018ASSIGNED TO LIE
Thursday, September 20, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 14, 2018NEW APPLICATION ENTERED IN TRAM